Your browser doesn't support javascript.
loading
Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation.
Noubissi Nzeteu, Gaetan Aime; Schlichtner, Stephanie; David, Sulamith; Ruppenstein, Aylin; Fasler-Kan, Elizaveta; Raap, Ulrike; Sumbayev, Vadim V; Gibbs, Bernhard F; Meyer, N Helge.
Affiliation
  • Noubissi Nzeteu GA; Division of General and Visceral Surgery, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • Schlichtner S; Division of Experimental Allergy and Immunodermatology, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • David S; Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United Kingdom.
  • Ruppenstein A; Division of Experimental Allergy and Immunodermatology, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • Fasler-Kan E; Division of Experimental Allergy and Immunodermatology, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • Raap U; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Sumbayev VV; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Gibbs BF; Division of Experimental Allergy and Immunodermatology, Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • Meyer NH; University Clinic of Dermatology and Allergy, University of Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany.
Front Immunol ; 13: 837097, 2022.
Article in En | MEDLINE | ID: mdl-35634346

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Immune Checkpoint Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Immune Checkpoint Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: Switzerland